Johns Hopkins ABX Guide
Trogarzo
INDICATIONS
FDA
FDA
- Treatment of HIV-1 infection in combination with other antiretrovirals in heavily treatment-experienced adults with multidrug-resistant HIV-1 infection failing their current antiretroviral regimen
NON-FDA APPROVED USES
NON-FDA APPROVED USES
N/A
There's more to see -- the rest of this topic is available only to subscribers.
Last updated: November 7, 2019
Citation
Bernice, Fidelia. "Trogarzo." Johns Hopkins ABX Guide, The Johns Hopkins University, 2019. Pediatrics Central, peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540735/all/Trogarzo.
Bernice F. Trogarzo. Johns Hopkins ABX Guide. The Johns Hopkins University; 2019. https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540735/all/Trogarzo. Accessed December 11, 2023.
Bernice, F. (2019). Trogarzo. In Johns Hopkins ABX Guide. The Johns Hopkins University. https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540735/all/Trogarzo
Bernice F. Trogarzo [Internet]. In: Johns Hopkins ABX Guide. The Johns Hopkins University; 2019. [cited 2023 December 11]. Available from: https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540735/all/Trogarzo.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Trogarzo
ID - 540735
A1 - Bernice,Fidelia,Pharm.D.
Y1 - 2019/11/07/
BT - Johns Hopkins ABX Guide
UR - https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540735/all/Trogarzo
PB - The Johns Hopkins University
DB - Pediatrics Central
DP - Unbound Medicine
ER -
